Common outcomes include: Gradual and sustainable weight loss Noticeable appetite reduction Improved portion control Fewer cravings Better metabolic stability Oral GLP-1 therapy is not one-size-fits-all
29.4 in Minerbi et al.) 14 , which is relevant because BMI can influence BA synthesis and composition
Interestingly, a human study has shown increases in plasma acylcarnitines with healthy aging ( APOE genotypes (Shang et al., 2020)
The most useful way to think about injection site reactions is to separate short-lived irritation from signs of infection, allergy, or a pattern that keeps coming back in the same spot
What is not yet visible: No skin tone changes, no measurable liver enzyme shifts, and no immune function differences at this stage
It is not worth the gamble